Biological Sample Collection: Clinical Trials

17 trials of Biological Sample Collection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 suspended. 17 Phase 2, 4 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 217Suspended 17
Phase 14Suspended 4
Phase 33Suspended 3

Follow Biological Sample Collection: new trials by email Literature Review of Biological Sample Collection trials Research Report on Biological Sample Collection

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery to Improve Treatment of Melanoma Brain Metastases
Emavusertib, Pembrolizumab, Stereotactic Radiosurgery - Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma
Phase 1 / Phase 2SuspendedMayo Clinic232026-11-302026-10-20
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Bone Marrow Collection - B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, T Acute Lymphoblastic Leukemia
Phase 2SuspendedUniversity of Washington302026-05-082026-09-29
ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma
Vevoctadekin, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 1 / Phase 2SuspendedFred Hutchinson Cancer Center332025-12-272026-09-11
External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Extramedullary Disease in Multiple Myeloma, Multiple Myeloma
Phase 1 / Phase 2SuspendedCity of Hope Medical Center202025-08-292026-10-07
Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma
Bcl-XL Proteolysis Targeting Chimera DT2216, Biospecimen Collection, Irinotecan - Childhood Fibrolamellar Carcinoma, Recurrent Childhood Fibrolamellar Carcinoma
Phase 1 / Phase 2SuspendedChildren's Oncology Group812025-06-122026-08-24
Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma
Phase 2SuspendedCity of Hope Medical Center332025-03-112026-01-21
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
Biopsy Procedure, Biospecimen Collection, Lomustine - Progressive Glioblastoma, Recurrent Glioblastoma
Phase 2SuspendedNational Cancer Institute (NCI)1842024-11-082026-11-03
Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Multiple Myeloma
Phase 2SuspendedNational Cancer Institute (NCI)842024-08-272026-10-19
High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer
Biospecimen Collection, BRC-001, Placebo Administration - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8
Phase 2SuspendedCity of Hope Medical Center362024-08-262026-07-14
Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery
Biopsy Procedure, Biospecimen Collection, Cisplatin - Resectable Intrahepatic Cholangiocarcinoma
Phase 2SuspendedNational Cancer Institute (NCI)272024-07-102026-09-04
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Biospecimen Collection, Bone Scan, Clinical Observation - Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2SuspendedMayo Clinic2362024-05-032026-08-20
Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer
Biospecimen Collection, Cabozantinib S-malate, Computed Tomography - Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma
Phase 2SuspendedNational Cancer Institute (NCI)502024-02-192026-11-02
Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery
Cemiplimab, Computed Tomography, Biospecimen Collection - Locally Advanced Basal Cell Carcinoma, Basal Cell Carcinoma
Phase 2SuspendedThomas Jefferson University702023-07-052026-06-10
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Atezolizumab, Biospecimen Collection, Computed Tomography - Extensive Stage Lung Small Cell Carcinoma
Phase 2 / Phase 3SuspendedNational Cancer Institute (NCI)1382021-01-072026-10-29
Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery
Biospecimen Collection, Carboplatin, Computed Tomography - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
Phase 2 / Phase 3SuspendedNational Cancer Institute (NCI)2782019-05-032026-11-02
Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma
Biopsy, Biospecimen Collection, Computed Tomography - Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8
Phase 2SuspendedM.D. Anderson Cancer Center1232018-06-142026-10-06
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Atezolizumab, Biopsy Procedure, Biospecimen Collection - Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2 / Phase 3SuspendedNational Cancer Institute (NCI)6132013-03-222026-11-02

Conditions studied

Multiple Myeloma (2)  ·  Adenocarcinoma Of Esophagus (1)  ·  Brain Neoplasms (1)  ·  Breast Carcinoma In Situ (1)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Basal Cell (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Carcinoma, Renal Cell (1)  ·  Fibrolamellar hepatocellular carcinoma (1)  ·  Glioblastoma (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Melanoma (1)  ·  Nasopharyngeal Carcinoma (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

National Cancer Institute (NCI) (7)  ·  City of Hope Medical Center (3)  ·  Mayo Clinic (2)  ·  Children's Oncology Group (1)  ·  Fred Hutchinson Cancer Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  Thomas Jefferson University (1)  ·  University of Washington (1)

Countries

United States (17)  ·  Canada (1)  ·  Hong Kong (1)

Top investigators

Alexandre V. Hirayama, MD (1)  ·  Ari J Rosenberg (1)  ·  Bently Doonan, MD, MS (1)  ·  Chad Tang (1)  ·  Hop S Tran Cao (1)  ·  Jennifer R Eads (1)  ·  Joseph Curry, MD (1)  ·  Lisa D Yee (1)  ·  Matthew P. Thorpe, M.D., Ph.D. (1)  ·  Michael Lim (1)  ·  Michael V Ortiz (1)  ·  Paul M Harari (1)  ·  Quynh-Nhu Nguyen (1)  ·  Ryan D. Cassaday, MD (1)  ·  Sascha A Tuchman (1)

Results publications

PMID 34717797, PMID 40915303, PMID 41671459

NIH funding

P30CA033572 (3), U10CA180821 (3), U10CA180868 (2), P30CA016672 (1), U10CA021661 (1), U10CA180820 (1), UM1CA186688 (1), UM1CA228823 (1)